Ebola vaccine trials launche amid security concerns
The News Large-scale trials of three vaccines against the deadly Bundibugyo Ebola strain in the epicenter of DR Congo’s outbreak could yield a breakthrough early next year if security challenges can be overcome, the head of a global vaccine body told Semafor.
- Similarly, Capobianco — who called eastern DR Congo a “complex environment in which to operate” — said the involvement of healthcare workers, religious leaders, and community authorities would be crucial in moving forward with trials.
- The Bundibugyo strain, for which there is no proven vaccine, has killed more than 5,500 people since May’s declaration of an outbreak — now the second-largest ever recorded.
- The Tumaini trial — a study to test vaccine candidates — will see jabs tested on at least 1,000 people to check their safety and efficacy.
Emanuele Capobianco, director of global health security at GAVI, a global vaccine alliance, in a separate interview, said if trials were successful, vaccines could potentially be deployed in the first half of 2027.
- “There is the potential, if the regulators approve, for expanded access to the vaccine while that review is going on,” he said.
- The two other vaccines, which were designed to target the Bundibugyo strain and will join the trial in the next few days, are a jab developed by Oxford University scientists and another by Moderna that harnesses technology used to create vaccines for COVID-19.
- He added that even if data suggested a vaccination was effective and safe, Congolese and global health regulators would still take time to conduct a review before issuing a formal decision about authorizing it for emergency use.
- Conflict and misinformation The Congolese army has for decades fought various rebel groups including M23, which DR Congo’s government has accused neighboring Rwanda of supporting — claims denied by Kigali.
- The View from Geneva “While the response has slowed transmission in the initial epicentres, 400 to 500 new cases continue to be reported each week,” the World Health Organization said in an update this week.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →